OBSOLETE: Classic paraneoplastic limbic encephalitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:163898
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Classic paraneoplastic limbic encephalitis (PLE) is a rare neurological condition classified as a paraneoplastic neurological syndrome, meaning it arises as an immune-mediated complication of an underlying cancer rather than from direct tumor invasion of the nervous system. This Orphanet entry (163898) is marked as OBSOLETE, indicating it has been reclassified or merged into broader categories of autoimmune or paraneoplastic encephalitis in current nosology. The condition primarily affects the limbic system of the brain, including the hippocampus, amygdala, and related structures, leading to prominent neuropsychiatric symptoms. Key clinical features of classic paraneoplastic limbic encephalitis include subacute onset of short-term memory loss, confusion, seizures, psychiatric disturbances (such as anxiety, depression, hallucinations, and personality changes), and sleep disturbances. The condition is most commonly associated with antibodies directed against intracellular neuronal antigens, particularly anti-Hu (ANNA-1), anti-Ma2/Ta, and anti-CV2/CRMP5 antibodies. Cancers most frequently implicated include small cell lung cancer, testicular germ cell tumors, breast cancer, and thymoma. Diagnosis relies on clinical presentation, detection of onconeural antibodies, brain MRI showing T2/FLAIR signal abnormalities in the medial temporal lobes, and identification of the underlying malignancy. Treatment focuses on addressing the underlying cancer, as tumor removal or reduction can sometimes lead to neurological stabilization or improvement. Immunotherapy, including corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange, rituximab, or cyclophosphamide, is used to modulate the immune response. However, prognosis in classic PLE associated with intracellular antibodies is often guarded, as neurological deficits may be partially irreversible due to neuronal damage. Early diagnosis and treatment of the underlying malignancy remain the most important prognostic factors.

Also known as:

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Classic paraneoplastic limbic encephalitis.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Classic paraneoplastic limbic encephalitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Classic paraneoplastic limbic encephalitis community →

No specialists are currently listed for OBSOLETE: Classic paraneoplastic limbic encephalitis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Classic paraneoplastic limbic encephalitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Classic paraneoplastic limbic encephalitisForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Classic paraneoplastic limbic encephalitis.

Start the conversation →

Latest news about OBSOLETE: Classic paraneoplastic limbic encephalitis

No recent news articles for OBSOLETE: Classic paraneoplastic limbic encephalitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Classic paraneoplastic limbic encephalitis

What is OBSOLETE: Classic paraneoplastic limbic encephalitis?

Classic paraneoplastic limbic encephalitis (PLE) is a rare neurological condition classified as a paraneoplastic neurological syndrome, meaning it arises as an immune-mediated complication of an underlying cancer rather than from direct tumor invasion of the nervous system. This Orphanet entry (163898) is marked as OBSOLETE, indicating it has been reclassified or merged into broader categories of autoimmune or paraneoplastic encephalitis in current nosology. The condition primarily affects the limbic system of the brain, including the hippocampus, amygdala, and related structures, leading to p

At what age does OBSOLETE: Classic paraneoplastic limbic encephalitis typically begin?

Typical onset of OBSOLETE: Classic paraneoplastic limbic encephalitis is adult. Age of onset can vary across affected individuals.